doc. Mgr. Martin Trbušek, Dr.

2017

• Rituximab-mediated release of CLL cells from lymph nodes to periphery: use of CD62L molecule as a marker.

  BORSKÝ Marek NOVOTNÁ Jitka BRYCHTOVÁ Yvona DOUBEK Michael MAYER Jiří TRBUŠEK Martin

  Conference abstract

  Year: 2017, type: Conference abstract

• Sada pro detekci přítomnosti mutací v genu ATM u pacientů s CLL

  TRBUŠEK Martin JAŠKOVÁ Zuzana KUBEŠOVÁ Blanka NAVRKALOVÁ Veronika ŠEBEJOVÁ Ludmila PLEVOVÁ Karla

  Year: 2017

2016

• Activation induced deaminase splice variants expressed in B cell leukemia and lymphoma do not retain their catalytic activity.

  ZÁPRAŽNÁ Kristína MALČÍKOVÁ Jitka TOM Nikola RADOVÁ Lenka TRBUŠEK Martin ATCHISON M. POSPÍŠILOVÁ Šárka

  Conference abstract

  Year: 2016, type: Conference abstract

• ATM gene mutations represent a hallmark of mantle cell lymphoma but do not impact patients survival.

  MAREČKOVÁ Andrea MALČÍKOVÁ Jitka TOM Nikola PÁL Karol ŠÁLEK David POSPÍŠILOVÁ Šárka TRBUŠEK Martin

  Conference abstract

  Year: 2016, type: Conference abstract

• ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: Enrichment in subset 2 is associated with markedly short telomeres

  NAVRKALOVÁ Veronika YOUNG Emma BALIAKAS Panagiotis RADOVÁ Lenka SUTTON Lesley-Ann PLEVOVÁ Karla MANSOURI Larry LJUNGSTRÖM Viktor NTOUFA Stavroula DAVIS Zadie JULIUSSON Gunnar SMEDBY Karin E. BELESSI Chrysoula PANAGIOTIDIS Panagiotis TOULOUMENIDOU Tasoula DAVI Frederic LANGERAK Anton W. GHIA Paolo STREFFORD Jonathan C. OSCIER David MAYER Jiří STAMATOPOULOS Kostas POSPÍŠILOVÁ Šárka ROSENQUIST Richard TRBUŠEK Martin

  Article in Periodical

  Haematologica, year: 2016, volume: 101, edition: 9, DOI

• Detailed analysis of chronic lymphocytic leukemia cases with single TP53 mutation

  PLEVOVÁ Karla MALČÍKOVÁ Jitka KOTAŠKOVÁ Jana TRBUŠEK Martin ŠMARDOVÁ Jana DIVÍŠKOVÁ Eva OLTOVÁ Alexandra BRYCHTOVÁ Yvona DOUBEK Michael POSPÍŠILOVÁ Šárka

  Conference abstract

  Year: 2016, type: Conference abstract

• Checkpoint kinase 1 inhibition potentiates apoptosis and inflicts mitotic failure in CLL-derived MEC-1 cell line.

  ZEMANOVÁ Jana HYLSE Ondřej ČOLLÁKOVÁ Jana VESELÝ Petr OLTOVÁ Alexandra PARUCH Kamil TRBUŠEK Martin

  Conference abstract

  Year: 2016, type: Conference abstract

• Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells

  ZEMANOVÁ Jana HYLSE Ondřej COLLAKOVA Jana VESELY Pavel OLTOVÁ Alexandra BORSKÝ Marek ZÁPRAŽNÁ Kristína KAŠPÁRKOVÁ Marie JANOVSKÁ Pavlína VERNER Jan KOHOUTEK Jiri DZIMKOVA Marta BRYJA Vítězslav JAŠKOVÁ Zuzana BRYCHTOVÁ Yvona PARUCH Kamil TRBUŠEK Martin

  Article in Periodical

  Oncotarget, year: 2016, volume: 7, edition: 38, DOI

• Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis

  PAVLASOVÁ Gabriela BORSKÝ Marek ŠEDA Václav ČERNÁ Kateřina OSIČKOVÁ Jitka DOUBEK Michael MAYER Jiří CALOGERO Raffaele TRBUŠEK Martin POSPÍŠILOVÁ Šárka DAVIDS Matthew S. KIPPS Thomas J. BROWN Jennifer R. MRÁZ Marek

  Article in Periodical

  Blood, year: 2016, volume: 128, edition: 12, DOI

• Monoallelic TP53 abnormalities in CLL: do they really exist? The frequency and clinical impact of copy-neutral loss of heterozygosity

  PLEVOVÁ Karla MALČÍKOVÁ Jitka ŠMARDOVÁ Jana DIVÍŠKOVÁ Eva KOTAŠKOVÁ Jana TRBUŠEK Martin BRYCHTOVÁ Yvona DOUBEK Michael POSPÍŠILOVÁ Šárka

  Conference abstract

  Year: 2016, type: Conference abstract